CHAM
RVMD icon

Clear Harbor Asset Management’s Revolution Medicines RVMD Stock Holding History

Clear Harbor Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-22,110
Closed -$1.03M – 473
2025
Q3 		$1.03M Buy
22,110
+8,394
+61% +$329K 0.07% 192
2025
Q2 		$505K Buy
13,716
+1,905
+16% +$73.2K 0.04% 274
2025
Q1 		$418K Buy
11,811
+587
+5% +$23.8K 0.03% 287
2024
Q4 		$491K Hold
11,224
– – 0.04% 240
2024
Q3 		$509K Hold
11,224
– – 0.04% 234
2024
Q2 		$436K Buy
11,224
+1,036
+10% +$38.7K 0.04% 240
2024
Q1 		$328K Buy
10,188
+2,988
+42% +$88.6K 0.03% 282
2023
Q4 		$206K Buy
+7,200
New +$173K 0.02% 326

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Clear Harbor Asset Management's RVMD Position: Q4 2025 in Review

Clear Harbor Asset Management sold out of Revolution Medicines (RVMD) in Q4 2025, closing a stake of 22,110 shares — an estimated $1.03M sold.

Clear Harbor Asset Management first reported a position in RVMD in Q4 2023 and held it in 8 quarters. The position peaked at $1.03M in Q3 2025. 386 funds tracked by Wall St. Rank hold RVMD as of Q4 2025.

  • Clear Harbor Asset Management reported no remaining Revolution Medicines position as of Q4 2025 after selling out during the quarter.
  • Clear Harbor Asset Management sold 22,110 Revolution Medicines shares in Q4 2025, an estimated $1.03M.
  • Clear Harbor Asset Management first reported a position in Revolution Medicines in Q4 2023 and held it in 8 quarters.
  • Clear Harbor Asset Management's Revolution Medicines position peaked at $1.03M in Q3 2025.
  • 386 funds tracked by Wall St. Rank held Revolution Medicines as of Q4 2025.

Based on Clear Harbor Asset Management's 13F filing for Q4 2025, filed 10 Feb 2026.